ArticleCancer research communications2022

Targeting OCT2 with Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neurotoxicity.

Mahesh R Nepal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.